Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus

Journal of Clinical Immunology

Volumn 33, Issue 4, 2013, Pages 767-774

  Yang, Xu Yan ^a   Wang, Hui Ying ^a   Zhao, Xiao Ying ^a   Wang, Li Juan ^a   Lv, Qing Hua ^a   Wang, Qing Qing ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

interleukin 17; interleukin 22; Systemic lupus erythematosus; T helper 1; T helper 22; T helper17

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; GAMMA INTERFERON; HYDROXYCHLOROQUINE; INTERLEUKIN 17; INTERLEUKIN 22; PREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN LUPUS ERYTHEMATOSUS; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH17 CELL; TH22 CELL;

ADULT; ANTIGENS, CD4; CELL SEPARATION; DERMATITIS; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH17 CELLS; YOUNG ADULT;

EID: 84878013708     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9878-1     Document Type: Article

References (42)

1. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-73.
2. Dolhain RJ, van der Heiden AN, ter Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:1961-9.
3. Wedderburn LR, Robinson N, Patel A, Varsani H, Woo P. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum. 2000;43:765-74.
4. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006;24:677-88.
5. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-β induces development of the TH17 lineage. Nature. 2006;441:231-4.
6. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-32.
7. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-41.
8. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of TH17 cells. Nature. 2008;453:1051-7.
9. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. New Engl J Med. 2009;361:888-98.
10. Dardalhon V, Korn T, Kuchroo VK, Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun. 2008;31:252-6.
11. Sullivan KE, Piliero LM, Dharia T, Goldman D, Petri MA. 3- polymorphisms of ETS1 are associated with different clinical phenotypes in SLE. Hum Mutat. 2000;16:49-53.
12. Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinflammatory Cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus. 2000;9:589-93.
13. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol. 2008;9:166-75.
14. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin17 by a subset of human skin-homing memory T cells. Nat Immunol. 2009;10:857-63.
15. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, et al. Th22 cells represent a distinct human T cell subsetinvolved in epidermal immunity and remodeling. J Clin Invest. 2009;119:3573-85.
16. Trifari S, Kaplan C, Tran E, Crellin N, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol. 2009;10:864-71.
17. Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related Tcell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol. 2000;164:1814-9.
18. Zhang N, Pan H-F, Ye D-Q. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem. 2011;353:41-6.
19. Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol. 2010;130:1373-83.
20. Truchetet ME, Brembillal NC, Montanari E, et al. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther. 2011;13:R166.
21. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60:1647-56.
22. Zhang L, Li JM, Liu XG, et al. Elevated Th22 Cells Correlated with Th17 Cells in Patients with Rheumatoid Arthritis. J Clin Immunol. 2011;31:606-14.
23. Ikeuchi H, Kuroiwa T, Hiramatsu N, et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 2005;52(4):1037-46.
24. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
25. Gladman DD, Ibanez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol. 2002;29:288-91.
26. Pan HF, Fnag XH, Wu GC, et al. Anti-neutrophil cytoplasmic antibodies in new-onset Systemic Lupus Erythematosus and lupus nephritis. Inflammation. 2008;31:260-5.
27. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241-54.
28. Wolk K, Witte E, Witte K, Warszawska K, Sabat R. Biology of interleukin-22. Semin Immunopathol. 2010;32:17-31.
29. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008;29:947-57.
30. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445:648-51.
31. Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S, et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest. 2008;118:597-607.
32. Wolk K, Haugen HS, Xu W, Witte E, Waggie K, Anderson M, et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med. 2009;87(5):523-36.
33. Kolb H, Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today. 1992;13:157-1601.
34. Jonuleit H, Dnop J, End AH. Cytokines and their effects on maturation, differentiation and migration of dendratic cells. Arch Dermatol Res. 1996;289:1.
35. Fairhurst AM, Mathian A, Connolly JE, et al. Systemic TNF-αdrives kidney nephritis in B6.Sle123 mice. Eur J Immunol. 2008;38(7):1948-60.
36. Jacob CO, Fronek Z, Lewis GD, et al. Heritable major histocompatibility complex class II-associated difference in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Nacl Acad Sci U S A. 1990;87:1233-7.
37. Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol. 2009;10:778-85.
38. Dong G, Ye R, Shi W, et al. IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients. Chin Med J (Engl). 2003;116:543-8.
39. Ma J, Yu J, Tao X, et al. The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients. Clin Rheumatol. 2010;29:1251-8.
40. Henriques A, Ines L, Couto M, et al. Frequency and functional activity of Th17, Tcl7 and other T-cell subsets in Systemic Lupus Erythematosus. Cell Immunol. 2010;264:97-103.
41. Funauclli MS, Ikoma H, Enomoto, et al. Decreased Thl-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol. 1998;27(3):p219-24.
42. Chang DM, Su WL, Chu SJ. The expression and significance of intracellular T helper cytokines in systemic 1upus erythematosus. Immunol Invest. 2002;31(1):1-12.